During the past decade, AARA Research Center conducted 20 clinical trials. In the 10-year time frame, 20 clinical trials started and 20 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 7 clinical trials started and 9 clinical trials were completed. i.e. 128.6% of trials that started reached the finish line.

Out of the total clinical trials conducted in "AARA Research Center" #1 sponsor was "Shire" with 20 trials, followed by "Meda Pharmaceuticals" with 7 trials sponsored, "CSL Behring" with 3 trials sponsored, "Grifols Therapeutics LLC" with 3 trials sponsored and "ADMA Biologics, Inc." with 3 trials sponsored. Other sponsors include 11 different institutions and companies that sponsored additional 20 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "AARA Research Center" #1 collaborator was "Takeda Development Center Americas, Inc." with 2 trials as a collaborator, "Atlantic Research Group" with 1 trials as a collaborator, "Dyax Corp." with 1 trials as a collaborator and "Shire Human Genetic Therapies, Inc." with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

According to Clinical.Site data, the most researched conditions in "AARA Research Center" are "Hereditary Angioedema" (16 trials), "Hereditary Angioedema (HAE)" (11 trials), "Seasonal Allergic Rhinitis" (5 trials), "Primary Immunodeficiency" (4 trials) and "Perennial Allergic Rhinitis" (2 trials). Many other conditions were trialed in "AARA Research Center" in a lesser frequency.

Most popular intervention types in "AARA Research Center" are "Drug" (33 trials), "Biological" (20 trials) and "Genetic" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (13 trials), "C1 esterase inhibitor [human] (C1INH-nf)" (5 trials), "ecallantide" (3 trials), "fluticasone propionate" (3 trials) and "0.15% azelastine hydrochloride" (2 trials). Other intervention names were less common.

The vast majority of trials in "AARA Research Center" are 51 trials for "All" genders.

Currently, there are NaN active trials in "AARA Research Center". undefined are not yet recruiting, 1 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 46 completed trials in AARA Research Center, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in AARA Research Center, 4 "Phase 1" clinical trials were conducted, 8 "Phase 2" clinical trials and 34 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 0 trials that are defined as “Not Applicable".